Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2762 |
|
Actual shortage: | 228 (8%) | |
Anticipated shortage: | 1 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2524 (91%) | |
Discontinuation Reports |
256 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 253 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
13 (6%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-10-03 | 2019-10-10 | 95370 |
TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-10-10 | 68572 |
PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94874 |
PORTIA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94870 |
TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94864 |
TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2019-10-03 | 2019-10-10 | 95387 |
PEMETREXED DISODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Resolved | 2019-09-05 | 2019-10-17 | 93140 |
TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-10-17 | 68569 |
ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2019-09-05 | 2019-10-17 | 93169 |
ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92229 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92180 |
APRI 28 | 0.15MG 0.03MG | TABLET | Resolved | 2019-08-29 | 2019-10-24 | 92660 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-29 | 2019-10-24 | 92666 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-29 | 2019-10-24 | 92669 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-09-05 | 2019-10-26 | 93156 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92678 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92681 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Resolved | 2019-10-17 | 2019-10-26 | 96730 |
AVIANE 28 | 20MCG 100MCG | TABLET | Resolved | 2019-09-26 | 2019-11-01 | 94828 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-11-01 | 95381 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |